A review of medical literature does not support monthly laboratory testing for all patients who are using standard doses of the acne medication isotretinoin. Isotretinoin has been associated with several adverse effects, including teratogenicity (causing birth defects) and hyperlipidemia. Prior studies have looked at the usefulness of laboratory monitoring during isotretinoin therapy.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1PxbQO8
No comments:
Post a Comment